A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Socially responsible companies are businesses that integrate social and environmental considerations into their core operations and decision-making processes.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

In a discussion with Oprah, Dr Ania called obesity a disease. She also advised that we should treat obesity like other ...